4 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 3 | Terminated 3 |
Follow Panuveitis: new trials by email Literature Review of Panuveitis trials Research Report on Panuveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants REGN7041 - Active Noninfectious Uveitis Affecting the Posterior Segment | Phase 1 / Phase 2 | Terminated | Regeneron Pharmaceuticals | 1 | 2025-12-17 | 2026-08-17 |
| Safety and Preliminary Efficacy Study of V404 PDS in Uveitis V404 - Uveitis, Posterior, Uveitis, Intermediate | Phase 1 / Phase 2 | Terminated | Forsight Vision4 | 7 | 2014-04-01 | 2016-12-09 |
| Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Methotrexate - Non-infectious Intermediate and Posterior Uveitis | Phase 1 / Phase 2 | Terminated | National Eye Institute (NEI) | 2 | 2011-02-01 | 2019-03-27 |
| Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome | Phase 1 | Terminated | Tehran University of Medical Sciences | 5 | 2007-12-01 | 2015-11-10 |
Uveitis (2) · Uveitis, Posterior (2) · Behcet Syndrome (1) · Macular Edema (1) · Papilledema (1) · Retinal Vasculitis (1) · Retinitis (1) · Uveitis, Intermediate (1)
Eye Diseases (4) · Uveal Diseases (4) · Retinal Diseases (2) · Uveitis (2) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cranial Nerve Diseases (1) · Genetic Diseases, Inborn (1) · Hereditary Autoinflammatory Diseases (1) · Macular Degeneration (1) · Mouth Diseases (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1) · Retinal Degeneration (1)
Methotrexate (2)
Forsight Vision4 (1) · National Eye Institute (NEI) (1) · Regeneron Pharmaceuticals (1) · Tehran University of Medical Sciences (1)
United States (3) · Iran (1)
Behrouz Nikbin, MD (1) · Fereydoun Davatchi, MD (1) · Hatice N Sen, M.D. (1) · Hormoz Shams, MD (1)
2025 (1)